Professor of Cardiology and Head of Research. Oslo University Hospital
Joined April 2013
- Tweets 357
- Following 1,349
- Followers 992
- Likes 628
41 Photos and videos
I am deeply honored by the occasion to receive the “outstanding research article 2025” award from our hospital OUS, for our BETAMI-DANBLOCK article in the NEJM.
This was huge teamwork, and I thanked the co-workers at OUS/UiO, my co-Chair, and the entire CV community in NO & DK.
2
15
698
Dan Atar retweeted
A great honor to welcome @ESC_President Thomas Lüscher to Bergen and the NCS Spring Meeting. His talk on AI and the future of cardiovascular medicine was truly thought-provoking.
(Take a look at the Elon Musk quote on the first photo🫣)
1
1
10
611
Glad to present online-streaming of JCS2026 with the session on guideline-changing evidence.
On demand streaming Site:
congre.co.jp/jcs2026/en/
Streaming Login: e416mb
A special thanks to Prof. Koichi Node, JCS2026-Chair, and Prof. Shinya Goto, my amazing host and co-Chairman.
132
Arrived in Tokyo. Huge hospitality @ Tokai University Hospital, by my friend Prof. Shinya Goto, a world renowned clinical scientist. Amazing experience just prior to embarking on the Shinkansen bullet train from Odawara to Fukuoka. My warmest thanks for this incredible reception.
1
10
176
Dan Atar retweeted
Rethinking β-blockers after MI
Our @NEJM Editorial integrates evidence from two recent IPD meta-analyses and outlines the emerging paradigm for β-blockade after MI.
👉 nejm.org/doi/full/10.1056/NE…
➡️ Time for personalized secondary prevention
@Borjaibanez1 @dan_atar @DLBHATTMD
1
22
72
5,309
CVCT stands out as a unique and most exciting “different” kind of conference where involvement across all stakeholders is key.
Huge congratulations to Faiez Zannad and Javed Butler to such a great achievement.
Honored to be back as faculty and to contribute to science.
8
299
Dan Atar retweeted
9 Dec 2025
At #CVCT2025 I reviewed the nonlinear basic discovery arc underlying clinical development from autologous #CDCs #postMI to #deramiocel for #Duchenne #cardiomyopathy culminating in the blockbuster #HOPE3 trial by @Capricor. Odyssean journey!
@SmidtHeart @CIRMnews @CoalitionDMD
3
7
38
1,277
#CVCT2025: Beta-blockers post-MI have been discussed for the last 50 years. Early trials firmly documented survival benefits, but the entire landscape has changed. Contemporary trials now provide clear answers.
Join us, December 8-10, Washington DC: lnkd.in/dyg5BMwm
#CVCT
1
157
And here with the registration link:
ESC 365 - Are beta-blockers still indicated after myocardial infarction?
myesc.escardio.org/MyESC/s/e…
46
Dan Atar retweeted
10 Sep 2025
My @TCTMD LBT interview with @dan_atar and @Borjaibanez1 around REBOOT-CNIC and BETAMI-DANBLOCK trials @escardio
➡️ tctmd.com/videos/beyond-the-…
@Hragy @mirvatalasnag @hvanspall @DrMarthaGulati @purviparwani @SVRaoMD @SandeepNathanMD @iamritu
14
26
3,314
Honored and humble to present the BETAMI-DANBLOCK trial on behalf of a combined Norwegian and Danish cardiovascular community. The main auditorium in Madrid was packed.
lnkd.in/dinhXrWD
#Oslo Center for Clinical Heart Research
1
154
Dan Atar retweeted
28 Aug 2025
#ESCCongress is almost here!
Don't miss 🔥 Hot Line discussions with 💫 Dr @hvanspall & expert guests: Prof @FaiezZANNAD, Prof @dan_atar, Dr Anna Meta Dyrvig Kristensen, Prof Michael Borger, Prof Udo Bavendiek, Prof @j_rvl & Dr Julie De Backer.
🫀 Cutting-edge insights, straight from this year's conference.
#ESCCongress2025 #ESC2025 #CardioEd
3
7
795
Exciting new clinical science coming your way at ESC. Join us on Saturday 30/8 at 11:00-12:00 CET.
#Oslo Center for Clinical Heart Research
17 Aug 2025
#ESCcongress2025 Hotine#3. Two large trials (@RebootTrial (n=8500) & betami danblock (n=5500 together)) PLUS a metaanalysis of them focused in the subgroup of Pt with mildly reduced LVEF are presented. Stay tuned!!
1
9
630
Dan Atar retweeted
17 Aug 2025
#ESCcongress2025 Hotine#3. Two large trials (@RebootTrial (n=8500) & betami danblock (n=5500 together)) PLUS a metaanalysis of them focused in the subgroup of Pt with mildly reduced LVEF are presented. Stay tuned!!
2
22
48
4,746